Baseline data of clinical ICU patients. by Jie Zhao (49409)

Subjects:

Analysis sample data. by Kazuhiro Suzuki (160528)

Subjects:

The results of SOM clustering. by Jeong-Soo Gim (18058588)

Subjects:

NGS datasets recovered from stomach contents of <i>E. erythropterus</i> in the NRE. by Jeong-Soo Gim (18058588)

Subjects:

Information of QTL interval and lead SNP significantly associated with meat color in fast-growing white-feathered chickens. by Jiahong Sun (6497603)

Characteristics of the participants. by Kazuhiro Suzuki (160528)

Subjects:

Participant demographic and clinical characteristics. by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. by Claire M. Douglas (21238238)

Subjects:

Diverse regulatory gate forms. by Jeong-Soo Gim (18058588)

Subjects:

The results of self-organising map (SOM) clustering. by Jeong-Soo Gim (18058588)

Subjects:

Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... by Claire M. Douglas (21238238)

Subjects:

Description of the study sites in the NRE. by Jeong-Soo Gim (18058588)

Subjects:

Correlation analysis of red blood cell-platelet ratio and coagulation indicators. by Jie Zhao (49409)

Subjects:

Prognostic model for the red blood cell-platelet ratio and its trajectory categories during hospitalization. by Jie Zhao (49409)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... by Claire M. Douglas (21238238)

Subjects:

Prognostic model for the red blood cell-platelet ratio and its trajectory categories during ICU stay. by Jie Zhao (49409)

Subjects:

CONSORT flow diagram depicting participant flow through the trial. by Leigh V. Evans (19753987)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance traini... by Claire M. Douglas (21238238)

Subjects:

Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

Weekly resistance training frequency over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects: